EXERENIBART
UNII T2CP32988Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Exerenibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T2CP32988Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2996101-49-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T2CP32988Q

CAS Registry Number

2996101-49-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

EXERENIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C215270

National Cancer Institute reference terminology for clinical and research data.

INN ID

13405

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Exerenibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EXERENIBART

Common Names & Synonyms

EXERENIBART [INN]

IMMUNOGLOBULIN G4 (232-PROLINE), ANTI-(HUMAN/MACACA FASCICULARIS/MUS MUSCULUS/RATTUS NORVEGICUS TRANSMEMBRANE SERINE PROTEINASE 6) (HUMAN MONOCLONAL REGN7999 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN7999 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS TMPRSS6 (TRANSMEMBRANE SERINE PROTEASE 6, MATRIPTASE-2, MT2)), HOMO SAPIENS MONOCLONAL ANTIBODY; H-GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-451) (VH (HOMO SAPIENS IGHV3-23*04 (95.9%) -(IGHD) -IGHJ1*01 (90.9%) L123>T (119), CDR-IMGT (8.8.17) (26-33.51-58.97-113)) (1-124) -HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, 12-G4V5 H P10 (CH1 (125-222), HINGE 1-12 S10>P (232) (223-234), CH2 L92 (313) (235-344), CH3 (345-449), CHS (450-451)) (125-451)), (138-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-214') (VKAPPA (HOMO SAPIENS IGKV1-12*01 (92.6%) -IGKJ3*01 (100%), CDRIMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (230-230'':233-233'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

Technical Codes

REGN7999

REGN-7999

External Clinical & Regulatory Resources

Previous UNIIT2CC8N0DQH

Next UNIIT2D4XUS623